A study to assess efficacy and clinical outcomes of HCV treatment with daclatasvir and sofosbuvir with or without ribavirin
Latest Information Update: 30 Jul 2020
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms B.A.R.C.O.S
- 30 Jul 2020 New trial record